Physician profile
Michael Denker
NPI 1164417580
$3,819.80
in general payments reported to CMS, 2019-2025
36 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $298 · 2021: $609 · 2022: $399 · 2023: $759 · 2024: $719 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,732 · Education: $25.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.65 |
| Education | $25.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $563.44 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $561.78 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $352.15 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $313.82 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $303.55 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Novo Nordisk INC | $211.92 | 2019-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $194.65 | 2019-2024 | Dificid |
| Novartis Pharmaceuticals Corporation | $108.65 | 2019-2024 | |
| Exact Sciences Corporation | $106.99 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $105.39 | 2022-2024 | Eliquis, Camzyos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.34 | 2019-2024 | Xifaxan, Trulance |
| Allergan, INC. | $84.59 | 2019-2020 | |
| Lilly USA, LLC | $78.46 | 2020-2025 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $68.70 | 2021-2022 | |
| Abbott Laboratories | $66.75 | 2021-2024 | Eterna, Freestyle Libre |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $65.15 | 2021-2024 | Ubrelvy |
| Medtronic, INC. | $59.69 | 2024 | Minimed 780g |
| Daiichi Sankyo INC. | $53.05 | 2019 | |
| Astellas Pharma US INC | $46.33 | 2019-2024 | Veozah, Myrbetriq |
| Hikma Pharmaceuticals USA | $43.31 | 2020-2022 | |
| Phathom Pharmaceuticals, INC. | $40.76 | 2024-2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $34.87 | 2025 | Rexulti |
| Sanofi Pasteur INC. | $29.00 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $28.64 | 2022 | |
| Medicure Pharma INC. | $27.81 | 2021-2022 | |
| Almatica Pharma LLC | $24.22 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $16.00 | 2023 | Gvoke Hypopen |
| Eisai INC. | $15.53 | 2024 | |
| Philips North America LLC | $15.50 | 2024 | (Ck7) Extended Holter |
| Shield Therapeutics INC | $15.42 | 2022 | |
| Genentech USA, INC. | $14.99 | 2019 | |
| Amgen INC. | $14.73 | 2024 | Repatha |
| Kowa Pharmaceuticals America, INC. | $14.24 | 2021 | |
| Eyevance Pharmaceuticals LLC | $13.64 | 2021 | |
| Horizon Therapeutics Plc | $13.54 | 2021 | |
| Circassia INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Denker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.